Figure 7.

Overview of the gating strategy for panel ONE 06: dendritic cell (DC) subsets. DCs and their subpopulations were identified, as previously reported [38-41]. The data file of the stained lysed (EDTA spiked) whole blood (WB) was analyzed as follows: exclusion of non-single events and gating of CD45⁺ leukocytes as shown for panel ONE 01 (Figure 2); gating of lineage (LIN; anti-CD3, anti-CD14, anti-CD19, anti-CD20, anti-CD56) negative HLA-DR⁺ cells, identification of LIN^-HLA-DR⁺CD11c⁺ myeloid DCs (mDCs), and LIN^-HLA-DR⁺CD11c^- cells (anti-CD11c versus anti-HLA-DR). Pre-gated mDCs were used to identify CD16⁺, mDC1, and BDCA3⁺mDC subsets, and pre-gated LIN^-HLA-DR⁺CD11c^- cells were used to identify plasmacytoid DCs (CD123⁺BDCA2⁺). DC, dendritic cell; mDC, myeloid dendritic cell; LIN, lineage; WB, whole blood.